Macrolane VRF 30 is a thicker gel suitable for areas with substantial tissue support and cover.
Macrolane is a hyaluronic acid-based product for body contouring and breast enhancement. Macrolane provides instant and long lasting results without the need for open surgery and therefore avoids some of the consequences such as scarring. It is injected into the breast in the sub-glandular level and subcutaneously for body contouring. The Macrolane gel is based on Q-Med's unique and patented NASHA™ technology.
What is NASHA gel?
NASHA gel is a crystal clear gel consisting of biotechnologically derived
hyaluronic acid that has been purified and stabilized. The hyaluronic acid is of non-animal origin, thus removing any risk of diseases transmitted by animals.
The hyaluronic acid is stabilized, i.e. minimally modified (~1%), to form a stable three-dimensional network. The unique patented NASHA technology gives a biologically degradable gel that has a long durability in the body.
Duration of treatments
A single treatment with Macrolane can last up to 12 months. The body slowly metabolizes the biocompatible Macrolane gel. If longer lasting results are desired, re-treatments can be made to maintain the aesthetic results.
What are possible side effects?
The most common side effect is slight soreness or swelling at the injection site, as expected for injection treatment. Non-prescription anti-inflammatory pills are usually sufficient to relieve the discomfort.
Perioperative infections have been reported. The signs and symptoms are usually increasing pain, redness and hardness affecting one breast, with or without systemic symptoms such as fever. A number of measures are recommended to minimize the potential risk for infection. The use of prophylactic antibiotics should be considered. It is important to ascertain that the patient does not have any concurrent skin infections prior to treatment. The procedure should be carried out in a clean environment with thorough skin preparation and use of aseptic techniques. Antibiotics treatment is best initiated after obtaining material for microbiological investigations.
Sometimes a capsule around the implant becomes contracted. This can happen with both traditional permanent implants as well as for Macrolane. If a patient with a traditional permanent implant gets a severe capsular contracture, commonly the implant has to be surgically removed.
If capsules arise in patients with Macrolane implants, most can be treated with closed capsulotomy (the breasts are manually compressed by the physician). The breasts usually soften after this treatment. Other options for treatment of capsules include gel aspiration or puncture of the capsule using a cannula.
Sometimes the capsular contracture reoccurs.
For detailed information regarding side effects, please review the Instructions for Use.